Alkermes (ALKS) Gross Profit Growth (3y) (2013 - 2026)
Alkermes (ALKS) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.95% |
| 10 | Alkermes | 8.76 Bn | 8.24 Bn | 331.33 Mn | 13.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.03% |
| Dec 31, 2025 | 10.50% |
| Sep 30, 2025 | 109.72% |
| Jun 30, 2025 | 101.53% |
| Mar 31, 2025 | 4.83% |
| Dec 31, 2024 | 10.75% |
| Sep 30, 2024 | 8.81% |
| Jun 30, 2024 | 10.45% |
| Mar 31, 2024 | 11.51% |
| Dec 31, 2023 | 9.04% |
| Sep 30, 2023 | 12.92% |
| Jun 30, 2023 | 39.88% |
| Mar 31, 2023 | 4.86% |
| Dec 31, 2022 | 100.37% |
| Sep 30, 2022 | -30.51% |
| Jun 30, 2022 | -30.77% |
| Mar 31, 2022 | 7.92% |
| Dec 31, 2021 | 97.37% |
| Sep 30, 2021 | 5.33% |
| Jun 30, 2021 | -1.38% |